The Valley Desk

Clinical trial reportExpert opinion on biological therapyPublished

Efficacy of nipocalimab in patients with moderate-to-severe ocular symptoms of generalized myasthenia gravis in the phase 3 Vivacity-MG3 study

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Expert opinion on biological therapy
Published
Subject terms
Humans; Myasthenia Gravis; Treatment Outcome; Activities of Daily Living; Severity of Illness Index; Double-Blind Method; Adult; Middle Aged; Female; Male; Antibodies, Monoclonal, Humanized; Myasthenia gravis
PubMed ID
42675831
Added to directory
Source checked

Report a correction or request removal